AAAAAA

   
Results: 1-8 |
Results: 8
PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS
Authors: DEMETER LM MEEHAN PM MORSE G FISCHL MA PARA M POWDERLY W LEEDOM J HOLDENWILTSE J GREISBERGER C WOOD K TIMPONE J WATHEN LK NEVIN T RESNICK L BATTS DH REICHMAN RC
Citation: Lm. Demeter et al., PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 135-144
FUMAGILLIN ANALOG IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY
Authors: DEZUBE BJ VONROENN JH HOLDENWILTSE J CHEUNG TW REMICK SC COOLEY TP MOORE J SOMMADOSSI JP SHRIVER SL SUCKOW CW GILL PS
Citation: Bj. Dezube et al., FUMAGILLIN ANALOG IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY, Journal of clinical oncology, 16(4), 1998, pp. 1444-1449
SAFETY AND ANTIVIRAL ACTIVITY OF COMBINATION THERAPY WITH ZIDOVUDINE,ZALCITABINE, AND 2 DOSES OF INTERFERON-ALPHA(2A) IN PATIENTS WITH HIV- AIDS CLINICAL-TRIALS GROUP-STUDY-197
Authors: FISCHL MA RICHMAN DD SAAG M MENG TC SQUIRES KE HOLDENWILTSE J MEEHAN PM
Citation: Ma. Fischl et al., SAFETY AND ANTIVIRAL ACTIVITY OF COMBINATION THERAPY WITH ZIDOVUDINE,ZALCITABINE, AND 2 DOSES OF INTERFERON-ALPHA(2A) IN PATIENTS WITH HIV- AIDS CLINICAL-TRIALS GROUP-STUDY-197, Journal of acquired immune deficiency syndromes and human retrovirology, 16(4), 1997, pp. 247-253
PHASE I II STUDY OF THE TOXICITY, PHARMACOKINETICS, AND ACTIVITY OF THE HIV PROTEASE INHIBITOR SC-52151/
Authors: FISCHL MA RICHMAN DD FLEXNER C PARA MF HAUBRICH R KARIM A YERAMIAN P HOLDENWILTSE J MEEHAN PM
Citation: Ma. Fischl et al., PHASE I II STUDY OF THE TOXICITY, PHARMACOKINETICS, AND ACTIVITY OF THE HIV PROTEASE INHIBITOR SC-52151/, Journal of acquired immune deficiency syndromes and human retrovirology, 15(1), 1997, pp. 28-34
FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY
Authors: DEZUBE BJ VONROENN JH HOLDENWILTSE J REMICK S COOLEY TP CHEUNG TW SOMMADOSSI JP SHRIVER SL SUCKOW CW GILL PS
Citation: Bj. Dezube et al., FUMAGILLIN ANALOG (TNP-470) IN THE TREATMENT OF KAPOSIS-SARCOMA - A PHASE-I AIDS CLINICAL-TRIAL GROUP-STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 78-78
A PHASE-I STUDY OF THE SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF COMBINATION DIDANOSINE AND RIBAVIRIN IN PATIENTS WITH HIV-1 DISEASE
Authors: JAPOUR AJ LERTORA JJ MEEHAN PM ERICE A CONNOR JD GRIFFITH BP CLAX PA HOLDENWILTSE J HUSSEY S WALESKY M COONEY E POLLARD R TIMPONE J MCLAREN C JOHANNESON N WOOD K BOOTH DK BASSIAKOS Y CRUMPACKER CS
Citation: Aj. Japour et al., A PHASE-I STUDY OF THE SAFETY, PHARMACOKINETICS, AND ANTIVIRAL ACTIVITY OF COMBINATION DIDANOSINE AND RIBAVIRIN IN PATIENTS WITH HIV-1 DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 13(3), 1996, pp. 235-246
SHOULD COMMON CONTRAINDICATIONS FOR THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION PREVAIL
Authors: CARO JJ OBRIEN JA HOLDENWILTSE J ALPERT JS HARTZ SC
Citation: Jj. Caro et al., SHOULD COMMON CONTRAINDICATIONS FOR THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION PREVAIL, Circulation, 88(4), 1993, pp. 60-60
WHY DO WOMEN RECEIVE THROMBOLYSIS LESS OFTEN FOR ACUTE MYOCARDIAL-INFARCTION (AMI)
Authors: CARO JJ OBRIEN JA HOLDENWILTSE J ALPERT JS HARTZ SC
Citation: Jj. Caro et al., WHY DO WOMEN RECEIVE THROMBOLYSIS LESS OFTEN FOR ACUTE MYOCARDIAL-INFARCTION (AMI), Circulation, 88(4), 1993, pp. 508-508
Risultati: 1-8 |